- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01820273
Changes in Incretins Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy
August 5, 2019 updated by: Lund University
Study of Incretins Response and Glycemic Control: Pre Diet, After Conventional Weight Loss and in the Early Postoperative Phase After Gastric Bypass in T2D-patients.
The purpose of this study is to determine the early changes in gut hormonal, and other metabolites with known relations to the glycemic homeostasis.
The study mainly focus on these responses to food in the diabetic patient, compared to the non-diabetic, after gastric bypass surgery.
Also aiming for recording changes in the earliest postoperative phase.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kalmar, Sweden, 39185
- Kalmar County Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
female obese (BMI>35)patients accepted for bariatric surgery (lap gastric bypass).
10 patients with type 2 diabetes(T2D) 6 10 matched controls without T2D.
Description
Inclusion Criteria:
- clinical diagnosis of type 2 diabetes
- obesity BMI >35
Exclusion Criteria:
- prior bariatric surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
changes in incretines in the bariatric patient
Time Frame: 2 months prior to surgery - 6 weeks post surgery
|
standardized meals prior to pre op diet, day before surgery, first day after surgery and 6 weeks after surgery.
|
2 months prior to surgery - 6 weeks post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes control
Time Frame: 6 weeks post surgery
|
resolution of t2D as early as first day after surgery
|
6 weeks post surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Nils Wierup, Lunds Universitet, Clinical researchcenter
- Principal Investigator: Johan Berggren, MD, Lunds Universitet
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
August 1, 2019
Study Registration Dates
First Submitted
March 25, 2013
First Submitted That Met QC Criteria
March 27, 2013
First Posted (Estimate)
March 28, 2013
Study Record Updates
Last Update Posted (Actual)
August 7, 2019
Last Update Submitted That Met QC Criteria
August 5, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MRD-Study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.